A novel porous gelatin composite containing naringin for bone repair

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Chen, Kuo Yu ^a   Lin, Kuen Cherng ^b   Chen, Yueh Sheng ^b   Yao, Chun Hsu ^b  

^a NATIONAL YUNLIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; AURANTIIN; CALCIUM PHOSPHATE; GELATIN; GENIPIN; TARTARIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE CELL; BONE DEFECT; BONE REMODELING; CALVARIA; CELL ACTIVITY; CELL PROLIFERATION; COLORIMETRY; COMPOSITE MATERIAL; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VIVO STUDY; LEACHING; NONHUMAN; OSTEOBLAST; OSTEOCLAST ACTIVITY; PRIORITY JOURNAL; RAT;

EID: 84874521400     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/283941     Document Type: Article

References (34)

1. Ogose A., Kondo N., Umezu H., Hotta T., Kawashima H., Tokunaga K., Ito T., Kudo N., Hoshino M., Gu W., Endo N., Histological assessment in grafts of highly purified beta-tricalcium phosphate (OSferion) in human bones. Biomaterials 2006 27 8 1542 1549 2-s2.0-28444488032 10.1016/j.biomaterials.2005. 08.034 (Pubitemid 41739579)
2. Liu B. S., Yao C. H., Chen Y. S., Hsu S. H., In vitro evaluation of degradation and cytotoxicity of a novel composite as a bone substitute. Journal of Biomedical Materials Research A 2003 67 4 1163 1169 2-s2.0-0346123063
3. Yao C. H., Liu B. S., Hsu S. H., Chen Y. S., Tsai C. C., Biocompatibility and biodegradation of a bone composite containing tricalcium phosphate and genipin crosslinked gelatin. Journal of Biomedical Materials Research A 2004 69 4 709 717 2-s2.0-2942625707
4. Yao C. H., Liu B. S., Hsu S. H., Chen Y. S., Calvarial bone response to a tricalcium phosphate-genipin crosslinked gelatin composite. Biomaterials 2005 26 16 3065 3074 2-s2.0-10644273645 10.1016/j.biomaterials.2004.09.011 (Pubitemid 39647241)
5. Barradas A. M. C., Yuan H., van Blitterswijk C. A., Habibovic P., Osteoinductive biomaterials: current knowledge of properties, experimental models and biological mechanisms. European Cells and Materials 2011 21 407 429
6. Matsumoto G., Omi Y., Kubota E., Ozono S., Tsuzuki H., Kinoshita Y., Yamamoto M., Tabata Y., Enhanced regeneration of critical bone defects using a biodegradable gelatin sponge and β -tricalcium phosphate with bone morphogenetic protein-2. Journal of Biomaterials Applications 2009 24 4 327 342 2-s2.0-70449337340 10.1177/0885328208096523
7. Dong G. C., Hueih M. C., Yao C. H., A novel bone substitute composite composed of tricalcium phosphate, gelatin and drynaria fortunei herbal extract. Journal of Biomedical Materials Research A 2008 84 1 167 177 2-s2.0-36949041076 10.1002/jbm.a.31261 (Pubitemid 350244258)
8. Yao C. H., Liu B. S., Liu C. G., Chen Y. S., Osteogenic potential using a malleable, biodegradable composite added traditional Chinese medicine: in vitro and in vivo evaluations. The American Journal of Chinese Medicine 2006 34 5 873 886 2-s2.0-33750464892 10.1142/S0192415X06004351 (Pubitemid 44650991)
9. Yao C. H., Tsai H. M., Chen Y. S., Liu B. S., Fabrication and evaluation of a new composite composed of tricalcium phosphate, gelatin, and Chinese medicine as a bone substitute. Journal of Biomedical Materials Research B 2005 75 2 277 288 2-s2.0-27744551025 10.1002/jbm.b.30294 (Pubitemid 41609548)
10. Yao C. H., Tsai C. C., Chen Y. S., Chang C. J., Liu B. S., Lin C. C., Tsuang Y. H., Fabrication and evaluation of a new composite composed of tricalcium phosphate, gelatin and Chi-Li-Saan as a bone substitute. The American Journal of Chinese Medicine 2002 30 4 471 482 2-s2.0-0038352256 10.1142/S0192415X02000557 (Pubitemid 41758875)
11. Wong R. W. K., Rabie A. B. M., Traditional Chinese medicines and bone formation-a review. Journal of Oral and Maxillofacial Surgery 2006 64 5 828 837 2-s2.0-33646052020 10.1016/j.joms.2006.01.017
12. Hung T. Y., Chen T. L., Liao M. H., Ho W. P., Liu D. Z., Chuang W. C., Chen R. M., Drynaria fortunei J. Sm. promotes osteoblast maturation by inducing differentiation-related gene expression and protecting against oxidative stress-induced apoptotic insults. Journal of Ethnopharmacology 2010 131 1 70 77 2-s2.0-77955311368 10.1016/j.jep.2010.05.063
13. Wang X. L., Wang N. L., Zhang Y., Gao H., Pang W. Y., Wong M. S., Zhang G., Qin L., Yao X. S., Effects of eleven flavonoids from the osteoprotective fraction of Drynaria fortunei (Kunze) J. Sm. on osteoblastic proliferation using an osteoblast-like cell line. Chemical and Pharmaceutical Bulletin 2008 56 1 46 51 2-s2.0-38049115718 10.1248/cpb.56.46
14. Jeong J. C., Lee J. W., Yoon C. H., Lee Y. C., Chung K. H., Kim M. G., Kim C. H., Stimulative effects of Drynariae Rhizoma extracts on the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Journal of Ethnopharmacology 2005 96 3 489 495 2-s2.0-21644464629 10.1016/j.jep.2004.09.038 (Pubitemid 41556600)
15. Jeong J. C., Lee J. W., Yoon C. H., Kim H. M., Kim C. H., Drynariae Rhizoma promotes osteoblast differentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogenetic protein-2, alkaline phosphatase, type I collagen and collagenase-1. Toxicology In Vitro 2004 18 6 829 834 2-s2.0-4744351420 10.1016/j.tiv.2004.05.002 (Pubitemid 39311895)
16. Sun J. S., Lin C. Y., Dong G. C., Sheu S. Y., Lin F. H., Chen L. T., Wang Y. J., The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) on bone cell activities. Biomaterials 2002 23 16 3377 3385 2-s2.0-0035989718 10.1016/S0142-9612(02)00038-8 (Pubitemid 34615644)
17. Habauzit V., Sacco S. M., Gil-Izquierdo A., Differential effects of two citrus flavanones on bone quality in senescent male rats in relation to their bioavailability and metabolism. Bone 2011 49 5 1108 1116 10.1016/j.bone.2011.07. 030
18. Lu Y., Zhang C., Bucheli P., Wei D., Citrus flavonoids in fruit and taditional Chinese medicinal food ingredients in China. Plant Foods for Human Nutrition 2006 61 2 57 65 2-s2.0-33746253640 10.1111/j.1467-8411.2006.00178.x (Pubitemid 44091199)
19. Manthey J. A., Grohmann K., Phenols in citrus peel byproducts. Concentrations of hydroxycinnamates and polymethoxylated flavones in citrus peel molasses. Journal of Agricultural and Food Chemistry 2001 49 7 3268 3273 2-s2.0-0034852659 10.1021/jf010011r (Pubitemid 32845054)
20. Wu J. B., Fong Y. C., Tsai H. Y., Chen Y. F., Tsuzuki M., Tang C. H., Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. European Journal of Pharmacology 2008 588 2-3 333 341 2-s2.0-44649083061 10.1016/j.ejphar.2008.04.030
21. Wei M., Yang Z., Li P., Zhang Y., Sse W. C., Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model. The American Journal of Chinese Medicine 2007 35 4 663 667 2-s2.0-34548174431 10.1142/S0192415X07005156 (Pubitemid 47307704)
22. Mandadi K., Ramirez M., Jayaprakasha G. K., Faraji B., Lihono M., Deyhim F., Patil B. S., Citrus bioactive compounds improve bone quality and plasma antioxidant activity in orchidectomized rats. Phytomedicine 2009 16 6-7 513 520 2-s2.0-67349201661 10.1016/j.phymed.2008.09.001
23. Pang W. Y., Wang X. L., Mok S. K., Lai W. P., Chow H. K., Leung P. C., Yao X. S., Wong M. S., Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells. British Journal of Pharmacology 2010 159 8 1693 1703 2-s2.0-77950204604 10.1111/j.1476-5381.2010.00664.x
24. Zhou X., Zhang P., Zhang C., Zhu Z., Promotion of bone formation by naringin in a titanium particle-induced diabetic murine calvarial osteolysis model. Journal of Orthopaedic Research 2010 28 4 451 456 2-s2.0-77949533144 10.1002/jor.21002
25. Lin C. Y., Sun J. S., Sheu S. Y., Lin F. H., Wang Y. J., Chen L. T., The effect of Chinese medicine on bone cell activities. The American Journal of Chinese Medicine 2002 30 2-3 271 285 2-s2.0-1842847396 10.1142/S0192415X02000351 (Pubitemid 41758901)
26. Sato T., Morita I., Murota S., Involvement of cholesterol in osteoclast-like cell formation via cellular fusion. Bone 1998 23 2 135 140 2-s2.0-0032146196 10.1016/S8756-3282(98)00082-9 (Pubitemid 28379874)
27. Takahashi N., Akatsu T., Udagawa N., Sasaki T., Yamaguchi A., Moseley J. M., Martin T. J., Suda T., Osteoblastic cells are involved in osteoclast formation. Endocrinology 1988 123 5 2600 2602 2-s2.0-0023790708
28. Ciapetti G., Ambrosio L., Savarino L., Granchi D., Cenni E., Baldini N., Pagani S., Guizzardi S., Causa F., Giunti A., Osteoblast growth and function in porous poly ε -caprolactone matrices for bone repair: a preliminary study. Biomaterials 2003 24 21 3815 3824 2-s2.0-12444344779 10.1016/S0142-9612(03) 00263-1 (Pubitemid 36773615)
29. Sun J. S., Chang R. M., Alveolar mononuclear cells can develop into multinucleated osteoclasts: an in vitro cell culture model. Journal of Biomedical Materials Research 2000 52 1 142 147 10.1002/1097-4636(200010)52: 1<142::AID-JBM18>3.0.CO;2-F
30. Wong R. W. K., Rabie A. B. M., Effect of naringin on bone cells. Journal of Orthopaedic Research 2006 24 11 2045 2050 2-s2.0-33750872026 10.1002/jor.20279 (Pubitemid 44717966)
31. Wang X., Zhen L., Zhang G., Wong M. S., Qin L., Yao X., Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei-An in vitro efficacy study. Phytomedicine 2011 18 10 868 872 2-s2.0-79959921754 10.1016/j.phymed.2011.01.022
32. Zhang P., Dai K. R., Yan S. G., Yan W. Q., Zhang C., Chen D. Q., Xu B., Xu Z. W., Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. European Journal of Pharmacology 2009 607 1-3 1 5
33. Schmitz J. P., Hollinger J. O., The critical size defect as an experimental model for craniomandibulofacial nonunions. Clinical Orthopaedics and Related Research 1986 205 299 308 2-s2.0-0022516213 (Pubitemid 16011282)
34. Wong R. W. K., Rabie A. B. M., Effect of naringin collagen graft on bone formation. Biomaterials 2006 27 9 1824 1831 2-s2.0-28744452058 10.1016/j.biomaterials.2005.11.009 (Pubitemid 41759477)